TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹30 Cr | ₹13 Cr | ₹3.41 Cr | ₹0.45 Cr |
What is the latest Total Non-Current Liabilities ratio of TRIDENT LIFELINE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹3.41 Cr |
| Mar2022 | ₹0.45 Cr |
How is Total Non-Current Liabilities of TRIDENT LIFELINE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | 138.92 | |
| Mar2024 | ₹13 Cr | 273.03 | |
| Mar2023 | ₹3.41 Cr | 652.98 | |
| Mar2022 | ₹0.45 Cr | - | |
Compare Total Non-Current Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹318.1 Cr | -2.4% | 3.8% | 3.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -2.4% |
3.8% |
3.4% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses